Defining the role of systemic autoimmune markers in adult epilepsy: A focus on autoimmune-associated epilepsy.

Notably, for APLAs and anti‐TPO, the immune etiological group even demonstrated seemingly lower positivity rates compared with the other groups, although these differences did not reach statistical significance (0% vs. 19.3% vs. 28.1%, p = 0.21; and 0% vs. 11.0% vs. 8.8%, p = 0.88, respectively).

also in 111,027 other papers